Lu AE58054, an antagonist of the serotonin 6 (5-HT6) receptor was recently progressed into a phase 3 trial with 930 mild to moderate AD patients in combination with AchE inhibitor donepezil. This evidence concerns the gene ACHE and Alzheimer disease.